A share price of Omega Therapeutics Inc [OMGA] is currently trading at $0.90, down -5.25%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The OMGA shares have gain 13.09% over the last week, with a monthly amount drifted -22.41%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Omega Therapeutics Inc [NASDAQ: OMGA] stock has seen the most recent analyst activity on November 15, 2024, when Raymond James downgraded its rating to a Mkt Perform. Previously, Raymond James started tracking the stock with Outperform rating on June 18, 2024, and set its price target to $12. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $11 on December 08, 2022. Chardan Capital Markets initiated its recommendation with a Buy and recommended $12 as its price target on September 23, 2022.
Omega Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.75 and $6.30. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Omega Therapeutics Inc [NASDAQ: OMGA] shares were valued at $0.90 at the most recent close of the market. An investor can expect a potential return of 900.0% based on the average OMGA price forecast.
Analyzing the OMGA fundamentals
Trailing Twelve Months sales for Omega Therapeutics Inc [NASDAQ:OMGA] were 8.10M which represents 214.32% growth. Gross Profit Margin for this corporation currently stands at -0.6% with Operating Profit Margin at -9.16%, Pretax Profit Margin comes in at -9.03%, and Net Profit Margin reading is -9.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -2.13 and Total Capital is -0.58. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7900 points at the first support level, and at 0.6800 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0000, and for the 2nd resistance point, it is at 1.1000.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Omega Therapeutics Inc [NASDAQ:OMGA] is 1.61. As well, the Quick Ratio is 1.61, while the Cash Ratio is 1.26. Considering the valuation of this stock, the price to sales ratio is 6.15, the price to book ratio is 4.30.
